telmisartan has been researched along with Brain Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, T; Kawamata, T; Kobayashi, M; Kobayashi, T; Okada, Y; Shibata, N | 1 |
1 other study(ies) available for telmisartan and Brain Infarction
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Brain; Brain Infarction; Brain Ischemia; Cytoprotection; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Motor Cortex; Neurons; Phospholipases A2; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Recovery of Function; Signal Transduction; Stroke; Telmisartan | 2009 |